Category Specific RSS

pharmaust

PharmAust invited by FightMND to submit a funding request for up to $1.8m

Biotech company PharmAust (ASX: PAA) has been invited by not-for-profit organisation FightMND to submit a comprehensive grant application which could…

2 years ago

Drug that stops growth of cancerous cells shows positive results

12-year-old Louie the beagle had little time left once the vet diagnosed his lymphoma. To avoid the side effects of…

2 years ago

PharmAust completes dosing first cohort for MND treatment, patients respond positively

Every day, two people are diagnosed in Australia with a form of motor neurone disease (MND). MND entails a group…

3 years ago

A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma

As I write this there’s a tiny senior chihuahua with half an ear snuggled up on my lap, a jack russell…

3 years ago

The funs of chemistry: How this pharma company is tapping into lucrative waste management

Ever wondered how renewable fuel is made? Or how biodegradable plastics are created? There’s a lot that happens after you…

3 years ago

PharmAust shrinks proprietary tablet for use in COVID-19 trials

Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets.  The clinical stage…

4 years ago